11:12 AM EDT, 08/05/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were edging higher late Wednesday morning, up 0.2% to 1,940.47 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and semiconductor firm Sequans Communications ( SQNS ) , which rose 3.6% and 3.3% respectively. They were followed by argenx (ARGX) and Novo Nordisk ( NVO ) , which rose 3.2% and 2.8% respectively.

The decliners from continental Europe were led by internet ad firm Criteo ( CRTO ) and biopharmaceutical company Cellectis ( CLLS ) , which dropped 18% and 1.8% respectively. They were followed by telecommunications company Nokia ( NOK ) and biopharmaceutical company Grifols ( GRFS ) , which were down 1.5% and 1.3% respectively.

The gainers from the UK were led by pharmaceutical company AstraZeneca ( AZN ) and communications company WPP ( WPP ) , which increased 4.6% and 3.4% respectively. They were followed by educational publisher Pearson (PSO) and hospitality company Intercontinental Hotels Group ( IHG ) , which were up 2.5% and 2.1% respectively.

The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals ( BDRX ) and insurance company Prudential (PUK), which fell 8.1% and 4.7% respectively. They were followed by Akari Therapeutics ( AKTX ) and lender HSBC ( HSBC ) , which lost 3.6% and 3.2% respectively.